Juniper Pharmaceuticals, Inc. (JNP) Reaches $9.45 After 3.00% Down Move; Dicks Sporting Goods (DKS)’s Sentiment Is 0.71

May 13, 2018 - By Winifred Garcia

Dick's Sporting Goods, Inc. (NYSE:DKS) Logo

Dicks Sporting Goods Inc (DKS) investors sentiment decreased to 0.71 in 2017 Q4. It’s down -0.09, from 0.8 in 2017Q3. The ratio is negative, as 131 hedge funds increased or started new positions, while 185 sold and reduced equity positions in Dicks Sporting Goods Inc. The hedge funds in our database now hold: 71.75 million shares, down from 75.65 million shares in 2017Q3. Also, the number of hedge funds holding Dicks Sporting Goods Inc in top ten positions increased from 1 to 2 for an increase of 1. Sold All: 69 Reduced: 116 Increased: 64 New Position: 67.

The stock of Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) is a huge mover today! The stock decreased 3.08% or $0.3 during the last trading session, reaching $9.45. About 110,475 shares traded or 3.89% up from the average. Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) has risen 88.04% since May 13, 2017 and is uptrending. It has outperformed by 76.49% the S&P500.The move comes after 7 months negative chart setup for the $104.90 million company. It was reported on May, 13 by We have $9.17 PT which if reached, will make NASDAQ:JNP worth $3.15M less.

Ratings analysis reveals 67% of Dick’s Sporting Goods’s analysts are positive. Out of 6 Wall Street analysts rating Dick’s Sporting Goods, 4 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $65.0 while the high is $69.0. The stock’s average target of $67.33 is 111.00% above today’s ($31.91) share price. DKS was included in 6 notes of analysts from September 21, 2016. The firm has “Buy” rating given on Monday, January 30 by Goldman Sachs. Guggenheim initiated Dick's Sporting Goods, Inc. (NYSE:DKS) on Wednesday, September 21 with “Neutral” rating. UBS maintained the stock with “Buy” rating in Friday, December 9 report. As per Wednesday, November 16, the company rating was maintained by RBC Capital Markets. Wedbush initiated it with “Outperform” rating and $65.0 target in Wednesday, November 2 report. The firm has “Perform” rating given on Tuesday, February 21 by Oppenheimer.

Tyvor Capital Llc holds 5.24% of its portfolio in Dick's Sporting Goods, Inc. for 580,676 shares. Tensile Capital Management Llc owns 903,178 shares or 4.41% of their US portfolio. Moreover, Hhr Asset Management Llc has 3.97% invested in the company for 2.48 million shares. The Louisiana-based Diversified Investment Strategies Llc has invested 3.28% in the stock. Icm Asset Management Inc Wa, a Washington-based fund reported 78,445 shares.

More recent Dick's Sporting Goods, Inc. (NYSE:DKS) news were published by: which released: “Stocks To Watch: A Fed Head Talks Crypto” on May 12, 2018. Also published the news titled: “3 Stocks to Watch on Monday: Alphabet Inc (GOOGL), Dicks Sporting Goods Inc (DKS) and Facebook, Inc. (FB)” on May 07, 2018.‘s news article titled: “Bright Lights On Capitalist Woodstock, Tech Developers And Sports Betting” with publication date: May 05, 2018 was also an interesting one.

Dick's Sporting Goods, Inc. operates as a sporting goods retailer primarily in the eastern United States. The company has market cap of $3.33 billion. It provides hardlines, including sporting goods equipment, fitness equipment, golf equipment, and hunting and fishing gear products; apparel; and footwear products and accessories. It has a 10.6 P/E ratio. The firm also owns and operates Golf Galaxy, Field & Stream and other specialty concept stores; and e-commerce Websites, as well as Dick's Team Sports HQ, a youth sports digital platform that offers free league management services, mobile apps for scheduling, communications and live scorekeeping, custom uniforms and fan wear, and access to donations and sponsorships.

Analysts await Dick's Sporting Goods, Inc. (NYSE:DKS) to report earnings on May, 15. They expect $0.43 EPS, down 20.37% or $0.11 from last year’s $0.54 per share. DKS’s profit will be $44.90 million for 18.55 P/E if the $0.43 EPS becomes a reality. After $1.22 actual EPS reported by Dick's Sporting Goods, Inc. for the previous quarter, Wall Street now forecasts -64.75% negative EPS growth.

The stock increased 1.82% or $0.57 during the last trading session, reaching $31.91. About 2.18M shares traded. Dick's Sporting Goods, Inc. (DKS) has declined 26.26% since May 13, 2017 and is downtrending. It has underperformed by 37.81% the S&P500.

Among 5 analysts covering Juniper Pharmaceuticals Inc (NASDAQ:JNP), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Juniper Pharmaceuticals Inc has $33 highest and $6.75 lowest target. $17.25’s average target is 82.54% above currents $9.45 stock price. Juniper Pharmaceuticals Inc had 7 analyst reports since August 26, 2015 according to SRatingsIntel. The company was initiated on Tuesday, January 2 by Roth Capital. The company was initiated on Tuesday, January 26 by Northland Capital. The stock has “Neutral” rating by H.C. Wainwright on Friday, August 19. The firm has “Market Perform” rating by Northland Capital given on Thursday, August 18. The firm has “Buy” rating given on Wednesday, August 26 by TheStreet. On Monday, January 9 the stock rating was downgraded by Bernstein to “Market Perform”.

Juniper Pharmaceuticals, Inc., a womenÂ’s health therapeutic company, focuses on developing therapeutics that address unmet medical needs in women's health. The company has market cap of $104.90 million. The firm develops its products using its drug delivery technologies, including bioadhesive delivery system, a polymer designed to adhere to epithelial surfaces or mucosa for sustained and controlled delivery of active drug product; and a novel intra-vaginal ring technology. It currently has negative earnings. It markets CRINONE, a progesterone bioadhesive vaginal gel for progesterone supplementation or replacement as part of an assisted reproductive technology treatment for infertile women with progesterone deficiency.

Dick's Sporting Goods, Inc. (NYSE:DKS) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: